› Forums › General Melanoma Community › New reports on adjuvant therapies-targeted & immunotherapy
- This topic has 4 replies, 4 voices, and was last updated 3 years, 5 months ago by mrbill16323.
- Post
-
- October 2, 2020 at 5:46 pm
I am so pleased that effective adjuvant therapies are available for more melanoma peeps. This morning I put together a post on articles that report 5 year outcomes for debrafinib/trametinib, 3 year follow up on pembro (Keytruda), and outcomes at 4 years for ipi (Yervoy) and nivo (Opdivo) when used as adjuvant for melanoma patients. Many previous reports on adjuvant therapy are linked within. Since many of you are actively on that path, I thought it may be of interest. Here’s the link if you are: http://chaoticallypreciselifeloveandmelanoma.blogspot.com/2020/10/new-follow-up-data-confirms.htmlWishing you all a safe and peaceful weekend. Wear a mask! Be well. – celeste
Viewing 1 reply thread
- Replies
-
-
- October 2, 2020 at 7:43 pm
Thank you Celeste, for providing easy access to the research articles. I always want to look at the newest overall survival as the numbers from the past are outdated. I am on a 6 week Keytruda schedule, my second infusion will be on 10/6/20. While I won’t have a scan until November, I am encouraged by a regression of a large palpable mass on my left flank. It would be sweet to have a decreased tumor burden on that next scan! Thanks again for being a pioneer!
Cindy -
- October 7, 2020 at 9:10 pm
You are an awesome addition to this forum. Thank you so much.
-
Viewing 1 reply thread
- You must be logged in to reply to this topic.